147 participants
Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2016-04-20
- Start Date:
- 2013-10-31
- Completion:
- 2015-03-31
Conditions
- Hepatitis C
- Liver Disease
Interventions
- DRUG
No Results Yet